These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17046661)
1. Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategies. Kocisko DA; Caughey B Methods Enzymol; 2006; 412():223-34. PubMed ID: 17046661 [TBL] [Abstract][Full Text] [Related]
2. Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie. Kocisko DA; Engel AL; Harbuck K; Arnold KM; Olsen EA; Raymond LD; Vilette D; Caughey B Neurosci Lett; 2005 Nov; 388(2):106-11. PubMed ID: 16039063 [TBL] [Abstract][Full Text] [Related]
3. From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease. Geissen M; Leidel F; Eiden M; Hirschberger T; Fast C; Bertsch U; Tavan P; Giese A; Kretzschmar H; Schatzl HM; Groschup MH ChemMedChem; 2011 Oct; 6(10):1928-37. PubMed ID: 21755599 [TBL] [Abstract][Full Text] [Related]
4. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Priola SA; Caughey B; Raymond GJ; Chesebro B Infect Agents Dis; 1994; 3(2-3):54-8. PubMed ID: 7812655 [TBL] [Abstract][Full Text] [Related]
5. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Enari M; Flechsig E; Weissmann C Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893 [TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of pathological prion protein accumulation by small interfering RNAs. Daude N; Marella M; Chabry J J Cell Sci; 2003 Jul; 116(Pt 13):2775-9. PubMed ID: 12759373 [TBL] [Abstract][Full Text] [Related]
7. Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice. Pfeifer A; Eigenbrod S; Al-Khadra S; Hofmann A; Mitteregger G; Moser M; Bertsch U; Kretzschmar H J Clin Invest; 2006 Dec; 116(12):3204-10. PubMed ID: 17143329 [TBL] [Abstract][Full Text] [Related]
8. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Vilette D; Andreoletti O; Archer F; Madelaine MF; Vilotte JL; Lehmann S; Laude H Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4055-9. PubMed ID: 11259656 [TBL] [Abstract][Full Text] [Related]
9. Disease-associated prion protein in the dental tissue of mice infected with scrapie. Okada H; Sakurai M; Yokoyama T; Mohri S J Comp Pathol; 2010; 143(2-3):218-22. PubMed ID: 20202648 [TBL] [Abstract][Full Text] [Related]
10. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin. Mangé A; Crozet C; Lehmann S; Béranger F J Cell Sci; 2004 May; 117(Pt 11):2411-6. PubMed ID: 15126640 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein. Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207 [TBL] [Abstract][Full Text] [Related]
13. Resistance of cell lines to prion toxicity aided by phospho-ERK expression. Uppington KM; Brown DR J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369 [TBL] [Abstract][Full Text] [Related]
14. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues. Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541 [TBL] [Abstract][Full Text] [Related]
15. Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. Rudyk H; Vasiljevic S; Hennion RM; Birkett CR; Hope J; Gilbert IH J Gen Virol; 2000 Apr; 81(Pt 4):1155-64. PubMed ID: 10725446 [TBL] [Abstract][Full Text] [Related]
16. [Newly discovered forms of prion diseases in ruminants]. Laude H; Béringue V Pathol Biol (Paris); 2009 Mar; 57(2):117-26. PubMed ID: 18848406 [TBL] [Abstract][Full Text] [Related]
17. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030 [TBL] [Abstract][Full Text] [Related]
18. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication. Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680 [TBL] [Abstract][Full Text] [Related]
19. Antiprion activity of cholesterol esterification modulators: a comparative study using ex vivo sheep fibroblasts and lymphocytes and mouse neuroblastoma cell lines. Pani A; Norfo C; Abete C; Mulas C; Putzolu M; Laconi S; Orrù CD; Cannas MD; Vascellari S; La Colla P; Dessì S Antimicrob Agents Chemother; 2007 Nov; 51(11):4141-7. PubMed ID: 17709472 [TBL] [Abstract][Full Text] [Related]
20. Cell density-dependent increase in the level of protease-resistant prion protein in prion-infected Neuro2a mouse neuroblastoma cells. Nakamitsu S; Kurokawa A; Yamasaki T; Uryu M; Hasebe R; Horiuchi M J Gen Virol; 2010 Feb; 91(Pt 2):563-9. PubMed ID: 19812263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]